Idiopathic diffuse mesangiocapillary glomerulonephritis type i and type II: experience with 50 cases
Vaccarezza, A.; Rosenberg, H.; Cortés-Monroy, G.
Revista Medica de Chile 116(8): 717-722
1988
ISSN/ISBN: 0034-9887 PMID: 3255122 Document Number: 321877
Document emailed within 1 workday
Related Documents
Ono, F.; Yoshimatsu, M.; Oka, T.; Imagawa, D. 1971: Case of diffuse oesinophilic gastroenteritis with radiographic characteristics of adult type idiopathic pyloric hypertrophia Nihon Rinsho. Japanese Journal of Clinical Medicine 29(10): 2325-2328Mohar, A.; Suchil-Bernal, L.; Hernández-Guerrero, A.; Podolsky-Rapoport, I.; Herrera-Goepfert, R.; Mora-Tiscareño, A.; Aiello-Crocifoglio, V. 1997: Intestinal type: diffuse type ratio of gastric carcinoma in a Mexican population Journal of Experimental and Clinical Cancer Research: Cr 16(2): 189-194
Ratner, M.I.; Fedorova, N.D. 1997: The prognostic significance of the morphological type of chronic glomerulonephritis and of the tubulointerstitial changes depending on the clinical type of the disease Terapevticheskii Arkhiv 69(6): 10-13
Sugiyama, H.; Makino, H.; Wada, J.; Ota, K.; Nagake, Y.; Morioka, S.; Yamasaki, Y.; Shikata, K.; Kashihara, N.; Ikeda, S. 1993: A clinicopathological study of patients with immune complex type and pauci immune type rapidly progressive glomerulonephritis Nihon Jinzo Gakkai Shi 35(6): 777-782
Bernheim, J.; Griffel, B. 1976: Mesangiocapillary glomerulonephritis in adults Harefuah 90(11): 514-517
Mast, T.Christopher.; Kierstead, L.; Gupta, S.B.; Nikas, A.A.; Kallas, E.G.; Novitsky, V.; Mbewe, B.; Pitisuttithum, P.; Schechter, M.; Vardas, E.; Wolfe, N.D.; Aste-Amezaga, M.; Casimiro, D.R.; Coplan, P.; Straus, W.L.; Shiver, J.W. 2010: International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials Vaccine 28(4): 950-957
Gaspar, M.L.; Gallart, M.A.; Prevosti, E.F.; Miró, A.O.; Robert, L.P. 1975: Activation of the complement in mesangiocapillary glomerulonephritis and in syphilitic nephropathy Revista Clinica Espanola 137(1): 37-43
Cameron, J.S.; Ogg, C.S.; White, R.H.; Glasgow, E.F. 1973: The clinical features and prognosis of patients with normocomplementemic mesangiocapillary glomerulonephritis Clinical Nephrology 1(1): 8-13
Andino, R.; Hernández, Y.; Monasterio, F.; Bernis, C. 2008: Necrotizing fasciitis and acute renal failure in mesangiocapillary glomerulonephritis Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 28(2): 231-232
Danilewicz, M.; Wagrowska-Danilewicz, M. 1996: Quantitative analysis of primary proliferative mesangial glomerulonephritis (PMGN) and diffuse form of idiopathic IgA nephropathy (IgAN). Variants of the same morphological process? Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists 47(2): 73-78
Hirano, H. 1980: Electron microscopic studies of chronic glomerulonephritis. II. Mesangial reactions of advanced type of chronic glomerulonephritis Nihon Jinzo Gakkai Shi 22(10): 1285-1301
Raungratanaamporn, O.; Bhuripanyo, K.; Krittayaphong, R.; Aroonpruksakul, S.; Toomtong, P.; Chaithiraphan, S. 1997: Radiofrequency catheter ablation in type i atrial flutter: preliminary experience of 10 cases Journal of the Medical Association of Thailand 80(7): 466-472
De Werra, P.; Morel-Maroger, L.; Leroux-Robert, C.; Richet, G. 1973: Glomerulonephritis with diffuse IgA deposits in the mesangium. Study of 96 adult cases Schweizerische Medizinische Wochenschrift 103(21): 761-768
McKean, D.J.; Podzorski, R.P.; Bell, M.P.; Nilson, A.E.; Huntoon, C.J.; Slack, J.; Dower, S.K.; Sims, J. 1993: Murine T helper cell-2 lymphocytes express type I and type II IL-1 receptors, but only the type I receptor mediates costimulatory activity Journal of Immunology 151(7): 3500-3510
De Sanctis, V. 2018: Type 1 and Type 2 diabetes in children and adolescents: a public health problem in Qatar. The experience of Pediatric Diabetes Center at Hamad General Hospital (HGH) of Doha Acta Bio-Medica: Atenei Parmensis 89(S5): 5-6
Antonaci, S.; Jirillo, E.; Garofalo, A.R.; Polignano, A.; Resta, F.; Pugliese, P.; Capurso, A.; Bonomo, L. 1988: Cell-mediated immune response in patients with type IIa, type IIb and type IV primary hyperlipoproteinaemia Cytobios 54(218-219): 181-189
Berntorp, E.; Jarevi, G.; Vedback, A.; Nilsson, I.M. 1986: Living adenovirus type 4 vaccine human t lymphotropic virus type iii antibodies in swedish hemophiliacs in relation to type and dosage of factor concentrate Thrombosis Research (Suppl 6): 18
Barruet, R.; Gbadoe, A.D. 2006: Le diabète de type 2 de l'enfant en afrique noire : Cinq premiers cas au Togo - Type 2 diabetes mellitus in children in black Africa : Description of first five cases in Togo Medecine Tropicale 66(5): 481-483
Jungers, P.; Dougados, M.; Tron, F.; Leibowitch, J.; Lesavre, P.; Droz, D.; Bach, J.F. 1979: Long-term course of 32 cases of diffuse proliferative lupus glomerulonephritis, treated with corticoids alone or combined with cyclophosphamide Journal d'Urologie et de Nephrologie 85(12): 855-858
Rathore, A.; Chatterjee, A.; Sivarama, P.; Yamamoto, N.; Singhal, P.K.; Dhole, T.N. 2009: Association of CCR5-59029 A/G and CCL3L1 copy number polymorphism with HIV type 1 transmission/progression among HIV type 1-seropositive and repeatedly sexually exposed HIV type 1-seronegative North Indians Aids Research and Human Retroviruses 25(11): 1149-1156